Received: 14 August 2018
Accepted: 18 October 2018
First Online: 20 November 2018
Ethics approval and consent to participate
: All of the studies were approved by institutional review board and independent ethics committees at participating sites and were conducted in accordance with the Declaration of Helsinki (registration numbers: United Kingdom ISRCTN82317088, LUMC METC P05.037, UMC Utrecht METC 05/169).Because this was a post hoc analysis, no specific consent was obtained above that received for each individual trial.
: Not applicable.
: YKOT is supported by the Dutch Kidney Foundation (KJPB12.028 and 17OKG04), Clinical Fellowship from the Netherlands Organization for Scientific Research (90713460). CCH and XL are employees of Crescendo Bioscience. EHS is an employee of Crescendo Bioscience and holds stock shares in Myriad Genetics. JMvL received fees from Arthrogene, MSD, Pfizer, Eli Lilly, and BMS and research grants from Astra Zeneca, Roche-Genentech. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.